Why I Don't Own Fortinet Stock! Analysis & Upside
1 extracted signal · 0 resolved · 1 still active
The Patient InvestorIndependent analyst profile- Source published
- 02 Nov 2026, 20:10 UTC
- Recorded by Tahlil Plus
- 03 Nov 2026, 00:40 UTC

AI-generated source summary
Fortinet (FTNT) experienced a significant post-earnings crash, dropping over 25% despite a reported 'double beat' on earnings. Analysis of the Q3'26 financial highlights shows strong year-over-year growth in billings (29%), product revenue (37%), and value of deals (51%), alongside solid operating margin (38%) and adjusted free cash flow margin (44%). However, total revenue growth was a more moderate 20%. The company's long-term product revenue growth has been strong, though service revenue growth has seen a slight deceleration, projected at 13% for 2026. Concerns arise from the projected deceleration in service revenue growth from 14% to 13% and a slight decrease in gross margin from 79%-81% to 79%-80.3%. Furthermore, the forward P/E ratio has historically been high, trading at 50x earnings at its peak and currently around 36x. With an assumed 15% EPS growth and a conservative P/E of 30x, the target price for 2026 is estimated at $265.75, implying an upside of 95%. However, the current valuation may already price in significant future growth, making the stock susceptible to downside if growth moderates or the market re-rates the P/E multiple downwards. The company's strategy to maintain gross margin while managing costs is noted, but the analyst believes the stock is still somewhat overvalued given the deceleration in key growth metrics and the high historical valuation multiples.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
